Retinopathy of prematurity: Results of 2 years follow up;Prematüre reti̇nopati̇si̇: 2 Yillik tarama sonuçlarimiz

Erciyes Tip Dergisi

Volumn 27, Issue 3, 2005, Pages 104-109

  Öner, Ayşe ^a   Özkiriş, Abdullah ^a   Güneş, Tamer ^a   Karaküçük, Sarper ^a   Erkiliç, Kuddusi ^a   Çetin, Neşide ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Retinopathy of prematurity; Risk factors

Indexed keywords

ARTICLE; BIRTH WEIGHT; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; INCIDENCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

EID: 27544480935     PISSN: 1300199X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mc Namara JA, Tasman W. Retinopathy of prematurity. Ophthalmology Clinics of North America 1990; 3: 413-427.
2. Roth AM. Retinal vascular development in premature infants. Am J Ophthalmol 1977; 84: 636-640.
3. Foss RY, Kopelow SM. Development of retinal vasculature in perinatal infants. Surv Ophthalmol 1973; 18: 117-127.
4. Akar S. Prematüre retinopatisi etyopatogenezi. Retina-Vitreus 1997; 5: 147-150.
5. Özcan A, Soylu M, Demircan N, Satar M, Narli N. Prematüre retinopatisi gelişimindeki risk faktörleri ve tedavi sonuçlari. Türk Oftalmoloji Gazetesi 1997; 27: 290-294.
6. Bozkurt N, Anveriazer M, Öǧüt MS, Kazokoǧlu H, Bavbek T, Özek E. Prematüre retinopatisi, risk faktörleri ve takip sonuçlari. Türk Oftalmoloji Gazetesi 1997; 29: 149-156.
7. Rudanko SL, Felman V, Laatikainen L. Visual impairment in children born prematurely from 1972 through 1989. Ophthalmol 2003; 110: 1639-1645.
8. Weinberger B, Laskin D, Heck DE, Laskin JD. Oxygen toxicity in premature infants. Toxicology and Applied Pharmacology 2002; 181: 60-67.
9. Palmer EA, Flynn JT, Hardy RJ, et al. The Cryotherapy for Retinopaturity Cooperative Group. Incidence and early course of retinopathy prematurity. Ophthalmol 1991; 98: 1630-1638.
10. Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Eng J Med 1981; 305: 1365-1371.
11. Gunn TR, Easdown J, Outerbridge EW, et al. Risk factors in retrolental fibroplasia. Pediatrics 1980; 65: 1096-1100.
12. Prendiville A, Schulenburg WE. Clinical factor associated with retinopathy of prematurity. Archives Children 1988; 63: 522-527.
13. Gültan E, Kutluk S, Önder F, Arsan S, Kural G. Prematüre retinopatisi gelişiminde etkili faktörler. Retina-Vitreus 1996; 3: 619-624.
14. Ziylan Ş, Ulaşan S, Çamurlu S.E, Özkozaci T, Karatekin G. Prematür retinopatisi risk faktörleri: Oksijen, gestasyonel yaş, doǧum aǧirliǧi. Medikal Network Oftalmoloji 2000; 7: 263-267.
15. Altunbaş H.H, Kir N, Ovali T, Daǧoǧlu T. Prematüre retinopatisi: Klinik seyir ve risk faktörleri. Türk Oftalmoloji Gazetesi 2002; 32: 286-290.